Steven Rodgers is a Partner of Morgan Stanley Capital Partners (MSCP). He is based in New York and has 22 years of investing experience.
Mr. Rodgers joined Morgan Stanley in 2018 from J.H. Whitney Capital Partners, where he was a Senior Managing Director focusing on private equity investments. At Whitney Mr. Rodgers was a member of the Investment Committee and led the firm’s healthcare investing activities. Mr. Rodgers was a Managing Partner at the Riverside Company, a global private equity firm, where he led the firm’s efforts to invest in public companies utilizing a private equity approach. He was also a financial analyst at Alex. Brown & Sons Incorporated. Mr. Rodgers serves on the board of directors of Aveanna Healthcare, 3B Scientific and previously served on the board of directors of a number of other healthcare companies, including Amisys Synertech, Herbalife, Patient Keeper, and Symbion.
Mr. Rodgers graduated, cum laude, from Dartmouth College, and holds an MBA from The Stanford University Graduate School of Business.
|Makes privately negotiated equity and equity-related investments in middle-market companies primarily located in North America.|